a lifestyle blog for book lovers
Menu
Bad Blood: Secrets and Lies in a Silicon Valley Startup
This story is fascinating. Despite knowing how the story ended, I couldn’t turn the pages fast enough to see how it all happened and who would be affected. Carreyrou covers the rise and fall of Elizabeth Holmes’ multi-billion dollar startup, Theranos, with thriller-like investigative journalism. Backed by impressive investors and promising faster and easier blood tests, Holmes and her associates seemed poised to take over the healthcare world. As Holmes becomes Silicon Valley’s rising star, her employees grow more and more concerned with their tense workplace environment and faulty technology. When Carreyrou steps in to investigate, the cover-ups, threats, and lies continue. A completely engrossing read.
About the Book
NEW YORK TIMES BEST SELLER • NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR, The New York Times Book Review, Time, Wall Street Journal, Washington Post • The McKinsey Business Book of the Year
The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech startup founded by Elizabeth Holmes—now the subject of the HBO documentary The Inventor—by the prize-winning journalist who first broke the story and pursued it to the end.
“The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.” —Bill Gates
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Other books in "10 Summertime Nonfiction Reads"
Look Inside
